Exhibit 99.2
Alphatec Holdings, Inc. Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock
CARLSBAD, California, August 2, 2019 – Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today announced the closing of its previously announced underwritten public offering of 12,535,000 shares of its common stock at a public offering price of $4.60 per share, which includes the full exercise of the underwriters’ option to purchase 1,635,000 additional shares of common stock to cover over-allotments.
Piper Jaffray and Canaccord Genuity acted as joint book-running managers in the offering. Lake Street Capital Markets acted asco-manager in the offering.
ATEC received gross proceeds of $57,661,000. ATEC intends to use the net proceeds from the offering, after deducting underwriting discounts and commissions and estimated offering expenses payable by ATEC, for general corporate purposes, including working capital, capital expenditures, and continued research and development with respect to products and technologies. A portion of the net proceeds of the offering may be used to fund possible investments in or acquisitions of complementary businesses, products, or technologies. ATEC currently does not have any agreements or commitments to complete any such transaction.
The shares of common stock are being issued and sold pursuant to a shelf registration statement on FormS-3 (FileNo. 333-221085) previously filed with and declared effective by the Securities and Exchange Commission. A final prospectus supplement and accompanying base prospectus relating to the offering each contain important information relating to ATEC’s shares of common stock. A final prospectus supplement and accompanying prospectus relating to the offering have been filed with the SEC and are available on the SEC’s website at www.sec.gov, and may also be obtained from Piper Jaffray & Co., Attention: Prospectus Department, 800 Nicollet Mall, J12S03, Minneapolis, MN 55402, via telephone at (800)747-3924 or via email at prospectus@pjc.com; or from Canaccord Genuity LLC, Attention: Syndicate Department, 99 High Street, Suite 1200, Boston, MA 02110, or by email at prospectus@cgf.com, or by phone at (617)371-3900.
This press release shall not constitute an offer to sell nor the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
